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Abstract
Background: End-stage renal disease carries a prognosis similar to cancer yet only 20 % of end-stage renal disease
patients are referred to hospice. Furthermore, conversations between dialysis team members and patients about
end-of-life planning are uncommon. Lack of provider training about how to communicate prognostic data may
contribute to the limited number of end-of-life care discussions that take place with this chronically ill population. In this
study, we will test the Shared Decision-Making Renal Supportive Care communication intervention to systematically elicit
patient and caretaker preferences for end-of-life care so that care concordant with patients’ goals can be provided.
Methods/design: This multi-center study will deploy an intervention to improve end-of-life communication for
hemodialysis patients who are at high risk of death in the ensuing six months. The intervention will be carried out as a
prospective cohort with a retrospective cohort serving as the comparison group. Patients will be recruited from 16
dialysis units associated with two large academic centers in Springfield, Massachusetts and Albuquerque, New
Mexico. Critical input from patient advisory boards, a stakeholder panel, and initial qualitative analysis of patient
and caretaker experiences with advance care planning have informed the communication intervention. Rigorous
communication training for hemodialysis social workers and providers will ensure that standardized study procedures
are performed at each dialysis unit. Nephrologists and social workers will communicate prognosis and provide advance
care planning in face-to-face encounters with patients and families using a social work-centered algorithm.
Study outcomes including frequency and timing of hospice referrals, patient and caretaker satisfaction, quality
of end-of-life discussions, and quality of death will be assessed over an 18 month period.
Discussion: The Shared Decision-Making Renal Supportive Care Communication intervention intends to
improve discussions about prognosis and end-of-life care with end-stage renal disease patients. We anticipate that the
intervention will help guide hemodialysis staff and providers to effectively participate in advance care planning for
patients and caretakers to establish preferences and goals at the end of life.
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Background
More than 600,000 patients in the United States have
end-stage renal disease (ESRD), with approximately
450,000 patients undergoing hemodialysis (HD) [1].
Mortality rates for hemodialysis patients are several fold
greater than those in the general population and dispro-
portionately higher rates occur in patients over the age
of 75. This elderly population also represents the fastest
growing segment of the chronic kidney disease (CKD)
population in the United States [1, 2]. Wong and associ-
ates recently reported that 49 % of elderly long-term HD
patients spent time in an intensive care unit (ICU) in
their final month of life compared with 24 % of cancer
patients – suggesting that patients with ESRD experi-
ence higher intensity of care at the end of life compared
to other Medicare beneficiaries with life-limiting ill-
nesses. This is consistent with the finding that only 20 %
of dying dialysis patients currently receives hospice care
while 55 % of people dying from cancer receive hospice
services [3, 4].
Most ESRD patients want to learn about end-of-life
(EOL) issues, such as treatment options (including with-
drawal from dialysis), and the availability of hospice ser-
vices [5, 6]. Discussing prognosis is a key step in EOL
planning, but occurs infrequently or late in the dying
process among patients with ESRD. In two studies, 95 %
and 97 % of patients with ESRD preferred to be given
life-expectancy information—even if their prognosis was
poor [5, 7]. Furthermore, patients specifically want their
physicians to disclose this information without prompt-
ing [5]. A validated prognostic tool exists for dialysis
patients [8], yet both uncertainty regarding individual
prognosis and a lack of training about how to communi-
cate prognostic data has limited EOL discussions be-
tween nephrologists and patients.
In this study, we will test the Shared Decision-Making
Renal Supportive Care (SDM-RSC) communication
intervention to determine its impact on EOL care and
outcomes. The intervention has been designed to sys-
tematically elicit patient preferences for EOL care so that
preference-concordant care can be provided. The study
outcomes will include the frequency and timing of hos-
pice referrals, location of death and the quality of EOL
planning discussions. Patient and caregiver satisfaction
and assessment of the quality of death will also be
assessed. The study will contribute to our understanding
of how communication regarding prognosis and EOL




This multi-center study is designed to test the effective-
ness of an intervention to improve EOL communication
for hemodialysis patients who are at high risk of death in
the ensuing six months. The intervention will be carried
out using a prospective cohort with a retrospective cohort
serving as the comparison group. In this multi-modal
intervention, nephrologists and social workers will com-
municate prognosis and provide EOL planning in face-to-
face encounters with patients and families using a social
work-centered algorithm. Follow-up sessions with the so-
cial worker will take place monthly following the initial
discussion to provide further support, education, informa-
tion, and referral to resources such as hospice.
Study sites
Patients will be recruited from 16 dialysis units associ-
ated with two large academic centers; eight units are af-
filiated with Baystate Medical Center in Springfield,
Massachusetts and eight are affiliated with the Univer-
sity of New Mexico in Albuquerque, New Mexico. Ag-
gregate demographic data for all dialysis units are
displayed in Table 1. The institutional review boards at
Baystate Medical Center and University of New Mexico
approved this study.
Participants
Prognosis will be determined for all patients attending the
study dialysis clinics by relying on a previously developed
prognostic tool [8]. Predictors of six-month mortality in
this instrument are age, serum albumin, absence/presence
of dementia, absence/presence of peripheral vascular dis-
ease and a modified Surprise Question (SQ). The SQ asks
nephrologists “Would you be surprised if this patient died
during the next six months?” Hemodialysis patients who
are 1) English or Spanish-speaking, 2) ≥ 18 years of age, and
3) who fall into the highest quartile of predicted mortality
risk are eligible for participation in this study. Exclusion cri-
teria include 1) having a diagnosis of a severe psychiatric
disorder (i.e. schizophrenia, bipolar disorder, etc., warrant-
ing hospitalization in the past month), 2) expectation of
native kidney function recovery, 3) scheduled for living
donor kidney transplant, 4) history of poor adherence to





Age (years) 64.9 60.6
Female 41.0 % 45.1 %
Black 13.9 % 3.0 %
Hispanic 9.5 % 52.3 %
Deaths (per 100 pt/year) 25.5 17.7
Diabetes mellitus 36.5 % 64.9 %
Average number of comorbid diseases 4.2 3.6
Percent of deaths with hospice 26.1 % 25.9 %
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hemodialysis treatments (i.e. missing ≥ 4 treatments in the
last month), and 5) exclusion by the primary nephrologist
or social worker due to risk of harm. Children < 18 years of
age will not be eligible for study participation as the phys-
ical factors related to ESRD are not directly comparable to
those of adults. Patients must be willing and able to sign
the consent form. If lacking capacity to meaningfully par-
ticipate in medical decisions, patients must have a surrogate
who is willing to sign the informed consent.
Intervention development
Qualitative study
We conducted in-depth interviews with patients and
families at both study locations. These interviews were
intended to expand our knowledge regarding ESRD pa-
tient and family perspectives on EOL planning and to
provide formative data for development of the interven-
tion. Patient and family members’ prior experiences with
preferences for EOL care were assessed. The qualitative
analysis confirmed that many patients want to hear
about prognosis and options for EOL care and that they
would like their nephrologists to be involved in these
discussions. Some patients also commented on developing
relationships with their social workers as they assisted
with care coordination and provided legal forms [9].
Stakeholder panel
This panel is composed of seven patient/family advocates,
administrators, and interdisciplinary clinician-researchers.
The former director of the ESRD Network of New
England chairs the panel. Members include representa-
tives of the largest for-profit and largest non-profit propri-
etary dialysis chains in the US, an experienced dialysis
nurse, leaders of two community hospice programs and
the director of the Patient and Family Council at one of
the main study academic centers. The panel provides crit-
ical input for all steps of the study, assists with the devel-
opment and implementation of the intervention, and will
facilitate national dissemination.
Patient advisory board
Each study site has a patient advisory board with a com-
bined total of 13 members. These boards are comprised
of patients from participating dialysis units. The Baystate
Medical Center board is chaired by a former chair of the
Baystate Patient Advocacy Board who has experience
with a family member undergoing dialysis. A palliative
medicine physician chairs the University of New Mexico
board. The patient advisory boards play a similar role to
the stakeholder panel, but provide patients’ perspectives
on decisions regarding study design, implementation,
and ultimately dissemination of results.
Intervention training
Social workers and nephrologists have been trained to
carry out the SDM-RSC intervention. Training included
introductory lectures to all of the nephrologists and social
workers caring for patients at the 16 intervention clinics.
These 60-min training sessions consisted of a study over-
view, review of previous research, and explanation of the
intervention. Trainees also will review a training tape
produced by the study investigators and members of the
stakeholder panel and patient advisory board (https://
www.youtube.com/watch?v=uzBE7uz3cm4). The video
models a patient-family-staff prognostic meeting [10–12],
and builds on the approaches used in both clinical practice
and clinical trials to improve communication with oncol-
ogy patients [12–16]. Didactic resources will include a
bibliography of recommended literature and the Renal
Physicians Association (RPA) Guidelines for the Initiation
and Discontinuation of Dialysis [17].
The dialysis social workers will be the principle facili-
tators of EOL communication between staff, patients,
and families. Accordingly, they underwent additional
training in an intensive one-day, interactive teleconfer-
ence sponsored by Baystate Medical Center and Smith
College School for Social Work [18]. The course trained
the social workers to facilitate EOL goal-setting and
prognostic communication during the SDM-RSC inter-
vention sessions. Social workers in both sites will also
engage in an eight-hour videoconference training on
communicating bad news, ethical and cultural issues,
and taking leadership on the team. They will continue to
meet through telephonic conferences to discuss clinical
and leadership matters. The introductory courses, training
video and didactic resources will be provided in binders
and uploaded to iPads. These will be distributed to the
social workers as additional resources.
Evaluation of intervention fidelity
Standardized training and monitoring are key strategies
to enhance the reliability and validity of the SDM-RSC
intervention [19]. Treatment fidelity of the intervention
will be enhanced by use of a checklist for social workers
and nephrologists to use during discussions with pa-
tients [18]. There will be regular monitoring to assess
for any variability in provider skills. A random selection
of 10 % of the initial staff-patient-family meetings will be
audiotaped with patients’ consent. The recordings will
be reviewed by study co-investigators to ascertain adher-
ence to the protocol. [20]
Recruitment
The investigators will use a multi-faceted approach to
recruitment. The staff of the dialysis units, including
nurses, technicians, physicians, and social workers will
be educated about the study rationale and scientific
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importance of the study. Special attention will be
accorded to the recruitment of eligible minority patients
to ensure diversity of the sample cohort.
Study procedures
We will collect baseline data for patients and caregivers
(see Table 2) at the time of enrollment. The initial pa-
tient and caretaker discussion will occur with the dialysis
nephrologist and social worker. Patient and caretaker
preferences for prognostic and EOL discussions will be
broached in this meeting with dedicated follow-up by
the social worker within 24 to 48 hours. Further data
collection will take place at distinct time intervals (see
Fig. 1). These will be assessed through interviews with the
study coordinators and dialysis social workers. Additional
data about hospice referrals will be collected from admin-
istrative data. Patient flow will be tracked to capture those
who are lost to follow-up and reasons for dropout.
Outcomes
The primary outcome for this intervention will be the
timing and percentage of hospice referrals. This will be
determined by administrative databases, as well as by
interviewing bereaved family members and the dialysis
staff. A secondary EOL outcome is the location of
participant death (i.e., home, hospital, ICU, or nursing
home) ascertained through the interviews with bereaved
families and the dialysis social workers who cared for
the patient prior to death. An additional secondary EOL
outcome is completion of advanced directive documents.
Caregivers will also be asked to respond to questions
about the quality of dying. Primary and secondary out-
comes are summarized in Table 3.
To determine patient and caregiver-reported outcomes,
instruments were selected to measure health-related quality
of life (HRQOL), pain, depression symptoms, satisfaction
with care, and caregiver distress (see Table 4) [21–26].
Analysis
Preliminary analyses will investigate differences in pa-
tient outcomes between the intervention and control pe-
riods. Initial analyses will also investigate trends in
hospice usage during the two years of retrospective data
collected for the control cohort. Smooth plots and gen-
eralized additive models with hospice use as the binary
outcome and date (measured as days from December
2009) as the independent predictor will be used to
model potential changes over time in the hospice usage
rate. If statistically significant non-linear associations are
found, then change over time will be modeled using
piecewise linear time variables. The extent of clustering
within the dialysis units during the control periods will
be estimated by the intra-class correlation coefficient.
The HRQOL and quality of dying measures will be sum-
marized and compared across the 16 study sites. Ana-
lyses will be done in SAS (version 9.3 or higher) with a
nominal type I error rate of 0.05.
Sample size and power
Over the 12 months of intervention enrollment we will
screen approximately 1048 patients at the 16 participating
sites, of which 25 % (n = 262) will be “highest risk,” as de-
termined by our validated model. We anticipate that 80 %
of these high risk patients will enroll in the study and fur-
ther expect that half of these patients will die during 18
months of follow-up, yielding at least 105 patients avail-
able for analysis. Hence, our sample size will be adequate
to account for a 5 % loss of data in follow-up due to with-
drawal from the study and the loss of power in accounting
for unit or site variation.
Discussion
The SDM-RSC intends to improve discussions about
prognosis and EOL care with ESRD patients. We antici-
pate that the intervention will encourage advanced care
planning and help patients establish EOL care prefer-
ences and goals. This study will examine whether the
intervention affects use of hospice services and whether
it influences patient outcomes such as hospitalizations,
location of death, quality of life, caregiver distress, and
quality of death. The intervention will be tested in di-
verse environments and geographic settings.
This is the first multi-center, prospective study de-
signed to test the hypothesis that EOL treatment can be
improved by identifying ESRD patients at high risk for
death and providing a systematic approach to discussing
prognosis and EOL preferences. The study is especially
novel as it brings patients and stakeholders together with
leading clinician-researchers who are interested in examin-
ing the integration of palliative medicine into the practice
of nephrology. The primary investigators have previously
conducted research involving severely ill and elderly
ESRD patients [27–32]. The study’s interdisciplinary
team contributes additional expertise in palliative care,
Table 2 Baseline assessment data
Patient level characteristics Age, sex, race, ethnicity, marital status, type of insurance, level of formal education, employment,
cause of ESRD, dialysis access, dialysis duration, comorbidities, income, household size, social support,
health behaviors, religious affiliation, history of renal transplant, routine laboratories, dialysis clearance,
functional status, health literacy, cognitive impairment, treatment adherence, and advanced directives
Caregiver characteristics Age, sex, race, ethnicity, and relationship to the participant
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communication, bioethics, psychiatry, and social work
education [17, 33]. Previous investigations regarding
EOL care have largely featured small observational stud-
ies or retrospective analyses [4, 5, 34]. For instance,
Schmidt et al. analyzed the deaths of 65 dialysis patients
in a single center hemodialysis unit over a five-year
period [34]. Although patients who were approached to
discuss dialysis withdrawal were less likely to die in the
hospital and more likely to use hospice, there was not a
consistent approach as to selection of patients or timing
of discussions. As our investigation targets patients at
the highest risk of dying, we will be investigating com-
munication between providers, patients and caretakers
during the most challenging emotional and physical cir-
cumstances. Furthermore, previous studies that have
featured patient surveys and interviews to elicit prefer-
ences and knowledge about EOL have typically not incor-
porated family or caretaker beliefs in the interventions
Fig. 1 Study Procedures. Abbreviations: SF-36 = Short Form – 36, SF-MPQ = Short Form McGill Pain Questionnaire, PHQ-9 = The Patient Health
Questionnaire, DSI = Dialysis Symptoms Index, PSQ = Patient Satisfaction Questionnaire, KATZ = Katz Index of Independence in Activities of Daily
Living, SP-MSQ = Cognition Short Portable Mental Status Questionnaire, SF-QDI = Short Family Quality of Death Interview, BQDA = Baystate Quality
of Dying Assessment
Table 3 Study outcomes
Study aims Primary Outcome Secondary Outcomes
EOL outcomes Hospice Use Location of death, Presence of advanced directives
Patient and caregiver-reported outcomes - Depressive symptoms, Caregiver satisfaction, Quality of life,
Pain symptoms, Caregiver distress, Quality of dying
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[5, 35]. Use of qualitative data to develop our interven-
tion and use of interdisciplinary interventional teams
among diverse patient populations are innovative ele-
ments of this study. Furthermore, reliance on patient ad-
visory boards and a stakeholder panel to shape the study
design and implement the intervention represent a unique
approach for improving delivery of prognostic information
and elicitation of EOL care preferences. These are consist-
ent with recommendations by the RPA for EOL care [17]
and the Institute of Medicine’s advocacy of patient-
centered healthcare [31, 36–39]. We believe that our com-
munication intervention has relevance to not only ESRD
but also other high-mortality disorders [13, 14, 20, 40–42].
This study will help establish whether delivery of prog-
nostic information, encouragement of advance directives,
and sensitive discussion of terminal treatment options,
can meaningfully alter the last portion of a patient’s life.
The proposed investigation may also gently confront the
issue of treatment overuse, as the HD literature has begun
to question the circumstances in which potential for harm
may exceed possible benefit [17, 43]. In summary, if the
SDM-RSC intervention is successful, it has the potential
to increase hospice use and significantly improve the qual-
ity of life for patients with severe kidney disease.
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